Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol in mild asthma
ACTRN12609000551291Phase 4Active, not recruiting
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Paracetamol with Placebo (2 arms). Primary endpoint: Bronchial hyper-responsiveness. Started Aug 2009; status: active, not recruiting.
02
Drugs
acetaminophen
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12609000551291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000551291.